Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase

Journal of Cell Science

Volumn 119, Issue 6, 2006, Pages 1005-1015

  Zhang, Xu Hannah ^a   Zhao, Chunying ^a   Seleznev, Konstantin ^a   Song, Keying ^a   Manfredi, James J ^a   Ma, Zhongmin Alex ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Ca2+ independent Phospholiphase A2; P53 dependent G1 arrest; Phospholipid turnover

Indexed keywords

ACTIN; CALCIUM ION; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROTEIN P21; PROTEIN P27; PROTEIN P53; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHASE TRANSITION; PHOSPHOLIPID METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; WESTERN BLOTTING;

CELL CYCLE; CELL DEATH; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; NAPHTHALENES; NOCODAZOLE; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PYRONES; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 33645742041     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02821     Document Type: Article

References (55)

1. 2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem. 270, 445-450.
2. Agami, R. and Bernards, R. (2000). Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102, 55-66.
3. Baburina, I. and Jackowski, S. (1999). Cellular responses to excess phospholipid. J. Biol. Chem. 274, 9400-9408.
4. Balsinde, J. and Dennis,E.A. (1996). Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J. Biol. Chem. 271, 31937-31941.
5. 2, prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc. Natl. Acad. Sci. USA 92, 8527-8531.
6. 2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J. Biol. Chem. 272, 29317-29321.
7. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y. et al. (1998). Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677.
8. 2, produce spermatozoa with impaired motility and have greatly reduced fertility. J. Biol. Chem. 279, 38194-38200.
9. 2. Biochim. Biophys. Acta 1439, 77-88.
10. Baumgartner, R., Fernandez-Catalan, C., Winoto, A., Huber, R., Engh, R. A. and Holak, T. A. (1998). Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Structure 6, 1279-1290.
11. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W. and Vogelstein, B. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501.
12. Burke, B. and Ellenberg, J. (2002). Remodelling the walls of the nucleus. Nat. Rev. Mol. Cell. Biol. 3, 487-497.
13. Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B. and Siliciano, J. D. (1998). Activation of the ATM Kinase by Ionizing radiation and phosphorylation of p53. Science 281, 1677-1679.
14. Colanzi, A., Suetterlin, C. and Malhotra, V. (2003). Cell-cycle-specific Golgi fragmentation: how and why? Curr. Opin. Cell Biol. 15, 462-467.
15. DeGregori, J., Kowalik, T. and Nevins, J. (1995). Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
16. Fadok, V. A. and Henson, P. M. (1998). Apoptosis: getting rid of the bodies. Curr. Biol. 8, R693-R695.
17. 2. J. Biol. Chem. 278, 44683-44690.
18. Gorina, S. and Pavletich, N. P. (1996). Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001-1005.
19. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
20. 2. J. Biol. Chem. 266, 7227-7232.
21. Higashitsuji, H., Itoh, K., Nagao, T., Dawson, S., Nonoguchi, K., Kido, T., Mayer, R. J., Arii, S. and Fujita, J. (2000). Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat. Med. 6, 96-99.
22. Jackowski, S. (1994). Coordination of membrane phospholipid synthesis with the cell cycle. J. Biol. Chem, 269, 3858-3867.
23. Jackowski, S. (1996). Cell cycle regulation of membrane phospholipid metabolism. J. Biol. Chem. 271, 20219-20222.
24. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J. and Thompson, C. B. (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283-293.
25. Kastan, M. B. and Bartek, J. (2004). Cell-cycle checkpoints and cancer. Nature 432. 316-323.
26. Kent, C. (995). Eukaryotic phospholipid biosynthesis. Annu Rev. Biochem. 64, 315-343.
27. Kojic, S., Medeot, E., Guccione, E., Krmac, H., Zara, I., Martinelli, V., Valle, G. and Faulkner, G. (2004). The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J. Mol. Biol. 339, 313-325.
28. Krzywda, S., Brzozowski, A. M., Higashitsuji, H., Fujita, J., Welchman, R., Dawson, S., Mayer, R. J. and Wilkinson, A. J. (2004). The crystal structure of gankyrin, an oncoprotein found in complexes with cyctin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. J. Biol. Chem. 279, 1541-1545.
29. Kubbutat, M. H., Jones, S. N. and Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
30. 2 and their effect on enzyme activity. J. Biol. Chem. 273, 207-214.
31. Lauber, K., Bohn, E., Krober, S. M., Xiao, Y. J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S. et al. (2003). Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113, 717-730.
32. Lykidis, A. and Jackowski, S. (2001). Regulation of mammalian cell membrane biosynthesis. Prog. Nucleic Acid Res. Mol. Biol. 65, 361-393.
33. 2. Prog. Nucleic Acid Res. Mol. Biol. 67, 1-33.
34. 2 enzyme that contains a repeated structural motif homologous to the integral membrane protein binding domain of ankyrin. J. Biol. Chem. 272, 11118-11127.
35. 2. Lipids 36, 689-700.
36. 2 activity. J. Biol. Chem. 279, 52881-52892.
37. Massague, J. (2004). G1 cell-cycle control and cancer. Nature 432, 298-306.
38. Mills, G. B. and Moolenaar, W. H. (2003). The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591.
39. Morgan, D. O. (1995). Principles of CDK regulation. Nature 374, 131-134.
40. Niculescu, A. B., 3rd, Chen, X., Smeets, M., Hengst, L., Prives, C. and Reed, S. I. (1998). Effects of p21 (Cipl/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629-643.
41. Nowak, S. J. and Corces, V. G. (2004). Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 20, 214-220.
42. Pappu, A. S. and Hauser, G. (1983). Propranolol-induced inhibition of rat brain cytoplasmic phosphatidate phosphohydrolase. Neurochem. Res. 8, 1565-1575.
43. 2 mediates lymphocyte proliferation. J. Biol. Chem. 275, 35692-35698.
44. Ryan, K. M., Phillips, A. C. and Vousden, K. H. (2001). Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337.
45. 2 inhibitors on 3T6 fibroblast proliferation. Biochem. Pharmacol. 61, 811-816.
46. 2 through arachidonic acid mobilization is involved in Caco-2 cell growth. J. Cell Physiol. 193, 293-298.
47. Serrano, M. (1997). The tumor suppressor protein p16INK4a. Exp. Cell Res. 237, 7-13.
48. Sherr, C. J. and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
49. Shieh, S. Y., Ikeda, M., Taya, Y. and Prives, C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
50. Smani, T., Zakharov, S. I., Csutora, P., Leno, E., Trepakova, E. S. and Bolotina, V. M. (2004). A novel mechanism for the store-operated calcium influx pathway. Nat. Cell Biol. 6, 113-120.
51. 2 results in insufficient insulin secretion and impaired glucose tolerance. Mol. Endocrinol. 19, 504-515.
52. 2 contains eight ankyrin motifs. J. Biol. Chem. 272, 8567-8575.
53. Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S. Y., Taya, Y., Prives, C. and Abraham, R. T. (1999). A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157.
54. Vogelstein, B., Lane, D. and Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
55. Vousden, K. H. and Lu, X. (2002). Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604.